ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
会议论文

Camrelizumab combined with lenvatinib and RALOX-HAIC for hepatocellular carcinoma (HCC) in BCLC stage B and C: A prospective, single-arm, phase II trial (Cal Era study)

Zang, M.; Li, Q.; Pang, H.; Hu, X.; Li, R.; Yuan, G.; Li, W.; Guo, Y.; Chen, J.南方医科大学
Annual Meeting of the European-Society-for-Medical-Oncology (ESMO)2022-9DOI: 10.1016/j.annonc.2022.07.850
14阅读
引用收藏
分享
相关
加载中…
  • Camrelizumab combined with lenvatinib and RALOX-HAIC for hepatocellular carcinoma (HCC) in BCLC stage B and C: A prospective, single-arm, phase II trial (Cal Era study)
    Chen, Jinzhang; Zang, Mengya; Pang, Huajin; Li, Chuanjiang; Zhao, Jianbo; Guo, Yabing; Hou, JinlinAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 2023-06-02 To 2023-06-06.被引 1
  • Camrelizumab (C) plus rivoceranib (R) vs. sorafenib (S) as first-line therapy for unresectable hepatocellular carcinoma (uHCC): A randomized, phase III trial
    Qin, S.; Chan, L. S.; Gu, S.; Bai, Y.; Ren, Z.; Lin, X.; Chen, Z.; Jia, W.; Jin, Y.; Guo, Y.; Sultanbaev, A. V.; Pazgan-Simon, M.; Pisetska, M.; Liang, X.; Chen, C.; Nie, Z.; Wang, L.; Cheng, A-L.; Kaseb, A.; Vogel, A.Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), ELECTR NETWORK, 2022-09-09 To 2022-09-13.被引 85
  • The efficacy and safety of cadonilimab combined with lenvatinib for first-line treatment of advanced hepatocellular carcinoma: A phase Ib/II clinical trial
    Bai, L.; Bai, Y.; Huang, M.; Shao, G.; Song, L.; Sun, M.; Wang, W.; Wu, J.; Xu, A.; Huang, L.; Liu, T.; Liu, W.; Wang, Z. M.; Li, B.; Xia, Y.Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), Barcelona, SPAIN, 2023-10-20 To 2023-10-24.
查看全部 →

会议信息

会议名称
Annual Meeting of the European-Society-for-Medical-Oncology (ESMO)
会议日期
2022-09-09 至 2022-09-13
论文集名
ANNALS OF ONCOLOGY
发表日期
2022-09
起止页码
S874-S874
DOI
10.1016/j.annonc.2022.07.850
资助标注
Clinical Research Plan of SHDC [SHDC2020CR4018]; National Natural Science Foundation of China [81902907, 81874182]; Shanghai Pujiang Program [2019PJD008]
收录
ISTP · SCIE

作者

  • Z

    Zang, M. (第一作者)

    southern med univ

  • L

    Li, Q.

    southern med univ

查看全部 9 位作者收起作者
  • P

    Pang, H.

    southern med univ

  • H

    Hu, X.

    southern med univ

  • L

    Li, R.

    southern med univ

  • Y

    Yuan, G.

    southern med univ

  • L

    Li, W.

    southern med univ

  • G

    Guo, Y.

    southern med univ

  • C

    Chen, J.

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417